Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates

Since its peak in early 2016, the incidence of Zika virus (ZIKV) cases has declined to such low levels that Phase 3 field efficacy trials may be infeasible. While great progress was made to rapidly advance several vaccine candidates into Phase 1 and 2 clinical trials, in the absence of sustained vir...

詳細記述

保存先:
書誌詳細
出版年:Vaccine
主要な著者: Vannice, Kirsten S., Cassetti, M. Cristina, Eisinger, Robert W., Hombach, Joachim, Knezevic, Ivana, Marston, Hilary D., Wilder-Smith, Annelies, Cavaleri, Marco, Krause, Philip R.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier Science 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357529/
https://ncbi.nlm.nih.gov/pubmed/30639461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.12.040
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料